Traditional Chinese versus integrative treatment in elderly patients with isolated systolic hypertension: A multicenter, randomized, double-blind controlled trial

Journal of Chinese Integrative Medicine

Volumn 8, Issue 5, 2010, Pages 410-416

  Li, Hao ^a   Liu, Long Tao ^a   Zhao, Wen Ming ^a   Liu, Jian Gang ^a   Yao, Ming Jiang ^a   Han, Yong Xiang ^b   Shen, Yan Peng ^b   Liu, Xing Dong ^c   Liu, Li ^a   Wang, Xue Mei ^a   Cai, Lin Lin ^a   Guan, Jie ^a  

^a XIYUAN HOSPITAL   (China)

^b Traditional Chinese Medicine Hospital of Yanqing County   (China)

^c Beijing Yanqing Center for Diseases Prevention and Control   (China)

Author keywords

Double blind method; Elderly; Hypertension; Integrative traditional Chinese and western medicine therapy; Multicenter trial; Randomized controlled trial; Traditional Chinese medicine therapy

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ENDOTHELIN 1; HERBACEOUS AGENT; JIANGYA; NIMODIPINE; NITRIC OXIDE; THROMBOXANE B2; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD PRESSURE MONITORING; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; HUMAN; INTEGRATIVE MEDICINE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC HYPERTENSION;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PHYTOTHERAPY; SYSTOLE;

EID: 77952396241     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20100503     Document Type: Article

References (11)

1. Linderstrom E, Boysen G, Nyboe J. Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study. Am J Epidemiol. 1995;142(12):1279-1290. (Pubitemid 26006427)
2. Li H, Liu LT. Considerations about clinical treatment on hypertension in elderly patients. J Chin Integr Med. 2009;7(7):607-610.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
4. The Revising Committee of Chinese Guidelines for Hypertension Prevention and Treatment. A revised version (2005) of Chinese guidelines for hypertension prevention and treatment. Gao Xue Ya Za Zhi. 2005;13(Suppl):241.
5. Li H, Liu F, Cui L, Xu LR, Luo ZG. Clinical study of Jiangya Capsule on 24 cases of elderly patients with isolated systolic hypertension. Zhong Yi Za Zhi. 2004;45(1):26-28.
6. Tomassoni D, Lanari A, Silvestrelli G, Traini E, Amenta F. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Clin Exp Hypertens. 2008;30(8):744-766.
7. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291(11):1342-1349.
8. Li SY, Xu KN, Huang JD, Fu YJ. Vascular endothelial function and its evaluation on elderly hypertensive patients. Shandong Yi Yao. 2008;48(28):36-37.
9. McEniery CM, Qasem A, Schmitt M, Avolio AP, Cockcroft JR, Wilkinson IB. Endothelin-1 regulates arterial pulse wave velocity in vivo. J Am Coll Cardiol. 2003;42(11):1975-1981.
10. 2, 6-keto-PGF1α and insulin in primary hypertensive patients. Xin Nao Xue Guan Bing Fang Zhi. 2001;1(2):27-28.
11. Xia CX, Lu S. Progress of study on improvement of vascular endothelial function by Chinese herbal medicine in hypertensive patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28(4):378-381.